Showing results (2191-2200 of 2,541) with videos related to

Sort By:
Pageof 255
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 12, 2026
From Ostrich to Mouse to Human: Translation of the Functional Liver PET Tracer [68Ga]Ga-TEoS-DAZAJulia Greiser, Robert Drescher, Mitali Sonawane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
Diagnostic evaluation of HER-2 as a molecular target: an assessment of accuracy and reproducibility of laboratory testing in large, prospective, randomized clinical trialsMichael F Press, Guido Sauter, Leslie Bernstein, et al.
Cancer Medicine|May 1, 2015
Reduced risk of breast cancer associated with recreational physical activity varies by HER2 statusHuiyan Ma, Xinxin Xu, Giske Ursin, et al.
Plos One|December 3, 2014
Anti-CD45 radioimmunotherapy with 90Y but not 177Lu is effective treatment in a syngeneic murine leukemia modelJohnnie J Orozco, Ethan R Balkin, Ted A Gooley, et al.
The Journal of Molecular Diagnostics : JMD|April 27, 2019
Analytical Validation of a Highly Sensitive, Multiplexed Chronic Myeloid Leukemia Monitoring System Targeting BCR-ABL1 RNAJustin T Brown, Ion J Beldorth, Walairat Laosinchai-Wolf, et al.
Alzheimer'S & Dementia (New York, N. Y.)|February 10, 2022
Gamma-induction in frontotemporal dementia (GIFTeD) randomized placebo-controlled trial: Rationale, noninvasive brain stimulation protocol, and study designMartina Assogna, Giulia Sprugnoli, Daniel Press, et al.
JMIR Research Protocols|February 7, 2024
Physical Activity Intervention for Urban Black Women With Asthma: Protocol for a Randomized Controlled Efficacy StudyEllen Davis, Elizabeth Townsend, Aero Cavalier, et al.
Breast Cancer Research : BCR|January 24, 2018
Body mass index at age 18 years and recent body mass index in relation to risk of breast cancer overall and ER/PR/HER2-defined subtypes in white women and African-American women: a pooled analysisHuiyan Ma, Giske Ursin, Xinxin Xu, et al.
Blood Advances|October 14, 2021
Megadose 90Y-ibritumomab tiuxetan prior to allogeneic transplantation is effective for aggressive large B-cell lymphomaVictor A Chow, Ryan D Cassaday, Theodore A Gooley, et al.
Blood|September 30, 2009
Allogeneic hematopoietic cell transplantation after conditioning with 131I-anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndromeJohn M Pagel, Theodore A Gooley, Joseph Rajendran, et al.
Pageof 255